Latest Business News Wires - Business Headlines


  • Weeks of fighting have exposed 20 years of neglect of Ukraine's security forces since the 1991 collapse of the Soviet Union. Eastern rebels that Kiev and the West say are backed by Russian special forces benefit from political vacillation, disarray among the generals and field commanders unsure of their orders.

  • *Vivus has 7 U.S. patents for Qsymia, earliest expires in June 2020. May 9- Vivus Inc said on Friday drugmaker Actavis Plc plans to market a generic version of Vivus's obesity drug Qsymia that was approved in July 2012.

  • HAVANA, May 9- In a land where the potato is scarce, black marketeers peddle tubers in hushed tones, like drug dealers on a big city street corner. Despite market-oriented reforms enacted by President Raul Castro, the communist-run country still encounters chronic shortages.

  • LONDON, May 9- U.S. drugmaker Pfizer, battling to buy British rival AstraZeneca, has struck a deal with leading British universities to hunt for new medicines to treat rare diseases.

  • NEW YORK, May 9- Some women will be eating bacon at Mother's Day brunches this Sunday. Overall, 40 percent of breadwinners in American households with children under the age 18 are women, according to the Pew Research Center, a nonpartisan fact tank.

  • May 9- 3 D printer maker Stratasys Ltd reported a 54 percent jump in quarterly adjusted revenue as it sold more higher-margin printers and services. Stratasys, which has traditionally focused on large industrial printers that sell for $15,000- $750,000, bought consumer printer MakerBot in a $493.7 million deal last year.

  • *Apple reportedly close to deal for Beats Electronics. *Apple Inc is close to paying a record $3.2 billion for Beats Electronics, two people with knowledge of the matter said, an expensive foray into music streaming and headphone gear.

  • *China pledges to promote fair and open capital markets. SHANGHAI, May 9- China pledged on Friday to push ahead with a broad range of capital market reforms as it seeks to encourage more efficient capital allocation, increase foreign investment and improve transparency of its markets.

  • ZURICH, May 9- Credit Suisse faced increased opposition from shareholders to its pay plan on Friday, as the Swiss lender became the latest major bank to come under attack over compensation.

  • May 9- Hilton Worldwide Holdings Inc raised its full-year profit forecast after strong business and leisure travel helped the company post better-than-expected quarterly results. Marriott International Inc and Hyatt Hotels Corp have also reported better-than-expected first-quarter earnings.

  • BEIJING, May 9- China is auditing the State Grid Corp of China, the utility said in the wake of a magazine report that one of the most senior executives in the world's largest utility was under investigation.

  • LONDON, May 9- The British government needs to be confident that any commitments made by Pfizer in a proposed takeover of AstraZeneca are binding, British Deputy Prime Minister Nick Clegg said on Friday.

  • *New Japanese processing plants coming up in China, Indonesia. Executives at steelmakers such as Nippon Steel& Sumitomo Metal Corp and JFE Holdings are faced with little choice but to accelerate their push abroad as the effects of the stimulus led by Prime Minister Shinzo Abe wane and spending on autos falls after a sales tax hike from April.

  • *Pvt equity has pumped $32 bln into shipping in past 2 yrs-fund mgr. SINGAPORE, May 9- The shipping industry faces a looming capacity glut as billions of dollars pumped into it by private equity have stoked a vessel-buying spree, threatening its prospects just as the sector is emerging from its worst downturn in three decades.

  • SHANGHAI, May 9- China issued new, detailed rules governing initial public offerings, seen as a signal that new listings will hit markets soon after a two-month hiatus while regulators tweaked regulations.

  • Vivus's diet pill faces generic threat from Actavis Friday, 9 May 2014 | 7:21 AM ET

    May 9- Vivus Inc said on Friday drugmaker Actavis Plc plans to market a generic version of Vivus's obesity drug Qsymia that was approved in July 2012. Actavis had filed a U.S. marketing application for its generic version of the diet pill, according to a notice sent by the generic drugmaker on May 7, Vivus said.

  • *CEO Maurice Levy says Publicis needs to be bigger. PARIS, May 9- Advertising agency Publicis will probably return money to shareholders and pursue smaller acquisitions this year as it seeks to get back on track after the failure of a $35 billion merger with U.S. peer Omnicom.

  • MUMBAI, May 9- Indian markets are so confident the opposition party led by Narendra Modi will win the country's elections that brokers fear anything short of a decisive victory could spark the worst sell-off in years.

  • Amazon's UK tax bill 10 mln stg on $7 bln sales Friday, 9 May 2014 | 7:10 AM ET

    LONDON, May 9- Amazon.com Inc filed accounts on Friday showing a UK tax bill of 10 million pounds despite $7.3 billion sales in Britain, because the company reports most of its European profit in a tax-exempt Luxembourg partnership. Amazon said it follows all the tax rules in every country where it operates.

  • *Vale says suspends nickel operations in New Caledonia. *China domestic copper market remains tight.